A New COVID Variant Is Emerging in Pennsylvania Near the Holidays

Pennsylvania — As the winter holidays draw near, a new COVID-19 subvariant known as JN.1 has surfaced in Pennsylvania and is suspected of being the cause of a rising percentage of coronavirus hospitalizations, according to officials.

Public health officials state that JN.1 has not replaced HV.1 as the predominant variety in Pennsylvania or the country. In the five states that make up the Centers for Disease Control and Prevention—Pennsylvania, Delaware, Maryland, Virginia, and West Virginia—JN.1 now accounts for 14.1% of all cases. After HV.1, which accounts for 35.4% of all cases, that is the second most.

According to CDC data, COVID-19 hospitalizations increased 1.55 percent in the country during the two weeks that ended on December 9 and increased

The Pennsylvania Department of Health has advised citizens to be vaccinated but has not specifically issued any alerts regarding JN.1.

Acting Secretary of Health Dr. Debra Bogen stated in a statement, "Getting vaccinated remains the most effective way to protect yourself against respiratory viruses that regularly circulate during the holiday season, when many of us attend gatherings with family and friends." "It’s safe to receive both the flu and COVID-19 vaccinations at the same time."Crucially, the number of COVID hospitalizations was lower than it was at this time last year and well below the peak of 150,650 hospitalizations on January 15, 2022.

Public health experts are still concerned about JN.1 since not enough people have received the revised vaccination. According to the CDC, the booster should guard against JN.1, and updated COVID testing ought to identify it along with other strains.

According to the CDC, 19.8% of Pennsylvanian individuals are immune to some form of vaccine.According to the CDC, there is no proof that the symptoms of JN.1 are worse than those of other strains, and an individual's immunity typically determines how severe their sickness is. According to Yale Medicine, although the virus's symptoms don't change much when it mutates, this one changes quickly, raising the possibility that it may be more adept at eluding immune systems.

The variant originated from BA.2.86, also known as Pirola, an Omicron variant. Scientists were concerned last summer that the variant would mutate past the point at which vaccines and antibodies could effectively combat it because to the over thirty alterations made to its spike proteins.

September saw the first JN.1 cases reported in the United States. The CDC estimates that the number of cases rose from 3.5 percent in mid-November to the current 21 percent.

The rise coincides with rising hospitalization rates for RSV and seasonal influenza, two major respiratory infections. Vaccination is the best thing that families can do for their members as they get together for the holidays, even if it typically takes a few weeks for protection to take effect.

Experts also recommend that those with symptoms remain at home. If it isn't feasible, think of disguising. When setting up seating, hosts should try to allow for social distancing, promote hand washing, and offer tissues and hand sanitizer in key locations where visitors would congregate.

Receive more local news directly in your inbox. Register for free Patch alerts and newsletters.